HomeAbout

TL;DR CNBC


AstraZeneca resumes U.S. Covid-19 vaccine trial and Johnson & Johnson prepares to do same - TL;DR CNBC

AstraZeneca resumes U.S. Covid-19 vaccine trial and Johnson & Johnson prepares to do same

Publishing timestamp: 2020-10-23 20:24:00


Summary


Sentiment: NEGATIVE

Tickers: AZN-GBJNJ

Keywords:

Source: https://www.cnbc.com/2020/10/23/astrazeneca-resumes-us-covid-19-vaccine-trial-johnson-johnson.html


Developed by Leo Phan